|
인쇄하기
취소
|
Multiple myeloma patients calls for earlier insurance coverage of Revlimid
Published: 2012-11-01 06:56:00
Updated: 2012-11-01 06:56:00
A group of patients suffering from multiple myeloma claimed that the national health insurance should cover Revlimid (lenalidomide) at an earlier date.
In a meeting with the National Health Insurance Corporation (NHIC) on Monday, patients said that the government should make a pricing deal with Celgene Korea on Revlimid, adding several patients were already dead over the past five months.
...
Fees
- Email service daily and homepage access.
- $300 per month.
- 5 Email holders per each company.
- Anual contract base.
Copyright Yakup.com All rights reserved.
약업닷컴의 모든 컨텐츠는 저작권법의 보호를 받습니다. 무단 전재⋅복사⋅배포 등을 금합니다.